Evidence map›Paper›PMID 41163216›Full record

ArticleHereditas2025

The microRNAs landscape of luminal B breast cancer cells in a three-dimensional microenvironment.

Stephanie I Nuñez-Olvera, Lorena Aguilar-Arnal, Jonathan Puente-Rivera, Alfredo Hidalgo-Miranda, Mireya Cisneros-Villanueva, Yarely M Salinas-Vera, Laurence A Marchat, María Elizbeth Álvarez-Sánchez, Karla Rubio, César López-Camarillo

Abstract read
In one paragraph

Article in Hereditas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stephanie I Nuñez-OlveraDepartamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, 04510, México.
Lorena Aguilar-ArnalDepartamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, 04510, México.
Jonathan Puente-RiveraDivisión de Investigación, Hospital Juárez De México, Ciudad de México, 07760, México.
Alfredo Hidalgo-MirandaLaboratorio Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, 14610, México.
Mireya Cisneros-VillanuevaLaboratorio Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México, 14610, México.
Yarely M Salinas-VeraPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México, 03100, México.
Laurence A MarchatPrograma Institucional de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía del Instituto Politécnico Nacional, Ciudad de México, 07320, México.
María Elizbeth Álvarez-SánchezPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México, 03100, México.
Karla RubioLaboratorio Internacional EPIGEN, Consejo de Ciencia y Tecnología del Estado de Puebla (CONCYTEP), Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, EcoCampus, Puebla, 72570, México.
César López-CamarilloPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México, 03100, México. cesar.lopez@uacm.edu.mx.

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías FORDECYT-PRONACES/51207/2020
6 · The paper itself

Abstract

backgroundThree-dimensional (3D) culture captures key features of tumor architecture and microenvironmental signaling. Because microRNAs (miRNAs) are central post-transcriptional regulators, we asked whether 3D growth would reveal disease-relevant lncRNA-miRNA-mRNA programs in BT-474 luminal breast cancer cells.

methodsBT-474 cells were profiled with GeneChip miRNA 4.0 microarrays to compare 3D versus 2D conditions. We then performed an integrative analysis consisting of: (i) extracting miRNA-mRNA interactions from miRNet and ENCORI (predicted and curated) for the differentially expressed miRNAs; (ii) identifying inverse miRNA-mRNA pairs (miRNA downregulated with target mRNA upregulated, or the reverse) using public mRNA data from BT-474 3D versus 2D cultures so that pairs were consistent with regulatory repression; and (iii) retaining only those miRNA-mRNA pairs that also appeared in miRNet/ENCORI. In a separate step, we examined public luminal breast tumor datasets versus BT-474 2D cultures to determine which 3D-identified miRNAs showed a similar direction of expression change in luminal tumors, thereby prioritizing signals with putative in vivo relevance. Finally, to enhance biological plausibility, we incorporated an lncRNA layer by leveraging their miRNA "sponge" (ceRNA) activity, and we assembled an integrated miRNA-mRNA-lncRNA network. Key miRNAs from this network were then evaluated for expression in external TCGA cohorts and for diagnostic potential using area-under-the-curve (AUC) analysis.

resultsOur data reveal a reprogramming of miRNA expression between 3D and 2D cultures. Using a threshold of FC > 1.5 and p < 0.05, we found 75 miRNAs upregulated and 82 downregulated in 3D relative to 2D. To strengthen biological interpretation, we integrated our miRNA expression data with public mRNA profiles from BT-474 cells cultured in 3D versus 2D. We then cross-referenced interactions reported in miRNet and ENCORI, retaining only miRNA-mRNA pairs showing inverse regulation. This integrative layer yielded a pathway-level view in which 3D-modulated miRNAs collectively favored proliferative programs, ESR1/estrogen signaling, MAPK/JNK activity, cell-cycle control, and extracellular-matrix remodeling, with relative attenuation of EGFR/TGF-β signaling. Together, the inferred miRNA-mRNA network supports a shift toward a more tumor-like, transcriptionally active state in 3D. To reinforce translational relevance, we cross-referenced public luminal breast tumor datasets with BT-474 2D cultures and identified 14 miRNAs in common, with the same direction of change as observed in 3D cultures. From these, we assembled co-regulatory networks linking miRNAs to their mRNA targets and to lncRNAs. This analysis highlighted four key miRNA nodes: miR-92a-3p, miR-539-5p, miR-18a-5p, and miR-130a-3p, which are connected to 58 mRNAs and modulated by 12 lncRNAs. The hubs converge on pathways for growth and survival via the RTK-MAPK axis, estrogen signaling, and fibronectin/adhesion-mechanotransduction processes, depicting a proliferative, mechano-responsive phenotype. Additionally, these miRNAs emerged as potential biomarker candidates: in TCGA datasets, miR-539-5p, miR-18a-5p, and miR-130a-3p are repressed in luminal breast tumors compared to normal breast tissue, each showing moderate to good diagnostic performance (AUC ~ 0.70-0.80).

conclusionOverall, this study highlights the utility of 3D cultures in investigating the biology of breast cancer, emphasizing the critical interplay between lncRNAs, miRNAs, and mRNAs. Our findings provide insights into the discovery of novel potential biomarkers, underscoring the importance of integrating both in vitro 3D culture and in vivo expression data for a more accurate identification of miRNAs with possible applications in cancer therapies.

Indexed as

Breast NeoplasmsMicroRNAsTumor MicroenvironmentCell Line, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansRNA, Long NoncodingRNA, MessengerMicroRNAsRNA, Long NoncodingRNA, Messenger3D culturesBreast cancerMicroRNAsMiRNA/lncRNAs/mRNA coregulation networks

Identifiers

PMID41163216
PMCPMC12574175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.